SAS Output

Organic Blind Sample Project

False Positive and Negative Report for

Method: 2440

Analyte	TestIDCode	CASNumber	# Samples Spiked	# False Negatives	# Samples Not Spiked	# False Positives
1,7-DIMETHYLXANTHINE_(P-XANTHINE)	67446LCM56	611-59-6	56	0	30	0
10-HYDROXY-AMITRIPTYLINE	67995LCM56	64520-05-4	31	0	55	0
ABACAVIR	68022LCM56	136470-78-5	55	0	31	0
ACETAMINOPHEN	67436LCM56	103-90-2	55	1	31	0
ACYCLOVIR	67484LCM56	59277-89-3	35	7	47	16
ALBUTEROL_(SALBUTAMOL)	67437LCM56	18559-94-9	55	0	31	0
ALPRAZOLAM	68250LCM56	28981-97-7	54	0	31	1
AMITRIPTYLINE	67522LCM56	50-48-6	53	1	33	0
AMPHETAMINE	67461LCM56	300-62-9	53	0	33	0
ANTIPYRINE	67477LCM56	60-80-0	54	0	32	0
ATENOLOL	67502LCM56	29122-68-7	57	2	29	0
ATRAZINE	65065LCM56	1912-24-9	56	4	30	5
BENZTROPINE	67997LCM56	86-13-5	54	2	32	1
BETAMETHASONE	67485LCM56	378-44-9	56	0	30	0
BUPROPION	67439LCM56	34911-55-2	55	0	31	0
CAFFEINE	67440LCM56	58-08-2	56	0	30	1
CARBAMAZEPINE	67441LCM56	298-46-4	56	0	30	1
CARISOPRODOL	67498LCM56	78-44-4	50	0	36	0
CHLORPHENIRAMINE	67497LCM56	132-22-9	51	2	35	0
CIMETIDINE	67442LCM56	51481-61-9	53	17	33	0
CITALOPRAM	67505LCM56	59729-33-8	36	0	50	0
CLONIDINE	67518LCM56	4205-90-7	54	0	32	0
CODEINE	67443LCM56	76-57-3	51	0	35	1
COTININE	67444LCM56	486-56-6	56	0	30	2
DEHYDRONIFEDIPINE	67445LCM56	67035-22-7	55	0	31	0
DESMETHYLDILTIAZEM	67999LCM56	130606-60-9	56	3	30	0
DESVENLAFAXINE	68251LCM56	93413-62-8	54	0	32	0
DEXTROMETHORPHAN	67468LCM56	125-71-3	55	0	31	0
DIAZEPAM_(VALIUM)	67499LCM56	439-14-5	54	0	32	0
DILTIAZEM	67519LCM56	42399-41-7	55	0	30	1
DIPHENHYDRAMINE	67447LCM56	147-24-0	54	2	32	0
DULOXETINE	67448LCM56	116539-59-4	34	1	52	0
ERYTHROMYCIN	67449LCM56	114-07-8	57	29	29	0
EZETIMIBE	67487LCM56	163222-33-1	56	0	30	0
FADROZOLE	68012LCM56	102676-47-1	56	1	30	0
FAMOTIDINE	68000LCM56	76824-35-6	56	9	30	0
FENOFIBRATE	67489LCM56	49562-28-9	54	7	32	0
FEXOFENADINE	67510LCM56	83799-24-0	55	1	31	0
FLUCONAZOLE	67478LCM56	86386-73-4	54	0	32	0
FLUOXETINE	67450LCM56	54910-89-3	55	0	31	0
FLUTICASONE_PROPIONATE	67529LCM56	80474-14-2	35	1	51	0
FLUVOXAMINE	67521LCM56	54739-18-3	57	0	29	0
GLIPIZIDE	68001LCM56	29094-61-9	56	0	30	0
GLYBURIDE	68002LCM56	10238-21-8	55	0	31	0
GUANYLUREA	52816LCM56	141-83-3	0	0	45	0
HYDROCODONE	67506LCM56	125-29-1	52	3	34	0
HYDROCORTISONE	67459LCM56	50-23-7	54	2	32	0
HYDROXYZINE	68005LCM56	68-88-2	34	0	32	0
IMINOSTILBENE	67481LCM56	256-96-2	55	2	31	0
KETOCONAZOLE	68014LCM56	65277-42-1	54	1	32	0
LAMIVUDINE	68018LCM56	134678-17-4	56	10	30	0
LIDOCAINE	67462LCM56	137-58-6	53	0	33	0
LOPERAMIDE	67515LCM56	53179-11-6	53	5	33	0
LORATADINE	67488LCM56	79794-75-5	57	0	29	0
LORAZEPAM	67470LCM56	846-49-1	50	0	36	0
MEPROBAMATE	67464LCM56	57-53-4	52	0	34	0
METAXALONE	67504LCM56	1665-48-1	30	0	47	6
METFORMIN	67492LCM56	657-24-9	57	0	29	0
METHADONE	67500LCM56	76-99-3	54	0	32	0
METHOCARBAMOL	67501LCM56	532-03-6	56	0	30	1
METHOTREXATE	67525LCM56	59-05-2	56	11	30	0
METHYL-1H-BENZOTRIAZOLE	67514LCM56	29385-43-1	55	0	31	0
METOPROLOL	67523LCM56	51384-51-1	55	0	31	0
MORPHINE	67458LCM56	57-27-2	53	2	33	0
NADALOL	68006LCM56	42200-33-9	56	0	30	0
NEVIRAPINE	68017LCM56	129618-40-2	56	0	30	0
NICOTINE	67493LCM56	54-11-5	54	3	32	0
NIZATIDINE	67479LCM56	76963-41-2	55	12	31	0
NORDIAZEPAM	68252LCM56	1088-11-5	52	0	34	0
NORETHINDRONE	67434LCM56	68-22-4	56	1	30	0
NORFLUOXETINE	67451LCM56	56161-73-0	36	0	50	0
NORSERTRALINE	67532LCM56	87857-41-8	28	0	58	0
NORVERAPAMIL	68007LCM56	67018-85-3	36	0	50	0
OMEPRAZOLE_+_ESOMEPRAZOLE	67512LCM56	000-12-13	55	1	31	0
OSELTAMIVIR	67511LCM56	196618-13-0	54	0	32	0
OXAZEPAM	67469LCM56	604-75-1	54	1	32	0
OXYCODONE	67495LCM56	76-42-6	52	0	34	0
PAROXETINE	67527LCM56	61869-08-7	56	3	30	0
PENCICLOVIR	68021LCM56	39809-25-1	55	8	31	0
PENTOXIFYLLINE	67480LCM56	6493-05-6	55	1	31	0
PHENAZOPYRIDINE	68008LCM56	94-78-0	56	0	30	0
PHENDIMETRAZINE	67496LCM56	634-03-7	0	0	86	0
PHENYTOIN	67466LCM56	57-41-0	56	0	30	0
PIPERONYL_BUTOXIDE	67435LCM56	51-03-6	57	2	29	0
PREDNISOLONE	67483LCM56	50-24-8	55	0	31	0
PREDNISONE	67467LCM56	53-03-2	56	0	30	0
PROMETHAZINE	67524LCM56	60-87-7	56	46	30	0
PROPOXYPHENE	68009LCM56	469-62-5	56	0	30	0
PROPRANOLOL	67516LCM56	525-66-6	55	0	31	0
PSEUDOEPHEDRINE+EPHEDRINE	67460LCM56	000-12-15	8	0	58	0
QUININE	68011LCM56	130-95-0	57	0	29	0
RACTOPAMINE	52814LCM56	97825-25-7	0	0	45	0
RALOXIFENE	67530LCM56	84449-90-1	54	1	32	0
RANITIDINE	67452LCM56	66357-35-5	54	20	32	0
SERTRALINE	67528LCM56	79617-96-2	55	0	31	0
SITAGLIPTIN	67531LCM56	486460-32-6	54	0	32	0
SULFADIMETHOXINE	67503LCM56	122-11-2	57	0	29	1
SULFAMETHIZOLE	67476LCM56	144-82-1	56	0	30	0
SULFAMETHOXAZOLE	67454LCM56	723-46-6	56	0	30	0
TAMOXIFEN	68015LCM56	10540-29-1	56	32	30	0
TEMAZEPAM	67471LCM56	846-50-4	53	3	33	0
THEOPHYLLINE	67494LCM56	58-55-9	36	2	48	10
THIABENDAZOLE	67455LCM56	148-79-8	55	3	31	0
TIOTROPIUM	67508LCM56	186691-13-4	35	5	51	0
TRAMADOL	67517LCM56	27203-92-5	32	1	54	0
TRIAMTERENE	67475LCM56	396-01-0	56	2	30	0
TRIMETHOPRIM	67456LCM56	738-70-5	56	0	30	0
VALACYCLOVIR	67507LCM56	124832-26-4	34	2	52	0
VENLAFAXINE	67534LCM56	93413-69-5	54	0	32	0
VERAPAMIL	67472LCM56	52-53-9	56	0	30	0
WARFARIN	67457LCM56	81-81-2	54	0	32	0

Organic Blind Sample Program

False Positives & False Negatives

1,7-DIMETHYLXANTHINE_(P-XANTHINE)

Method: 2440 Testid: 67446LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

10-HYDROXY-AMITRIPTYLINE

Method: 2440 Testid: 67995LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

ABACAVIR

Method: 2440 Testid: 68022LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

ACETAMINOPHEN

Method: 2440 Testid: 67436LCM56

Link to Individual Chart

False Positive & Negative Listing for ACETAMINOPHEN

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20171870123	Abs 060916PHARM: 80 µl & Abs 061416: 80 µl	20	07/15/17	< 20	36.16

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

ACYCLOVIR

Method: 2440 Testid: 67484LCM56

Link to Individual Chart

False Positive & Negative Listing for ACYCLOVIR

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20170680003	Crescent EN160610015: 40 µl & ERA 04281604: 40 µl	22	03/14/17	< 40	56
	20170680004	Crescent EN160610015: 40 µl & ERA 04281604: 40 µl	22	03/14/17	< 40	56
	20170740060	ERA 04281603: 40 µl & ERA 04281604: 40 µl	22	04/06/17	< 22	56
	20171790209	ERA 04281604: 40 µl & Abs 061516PHARM: 40 µl	22	07/15/17	< 22	56
	20172230004	Abs 072517Pharm1: 50 µl & Abs 071817Pharm: 50 µl	22	08/26/17	< 22	110
	20172370004	Abs 071817Pharm: 80 µl & Abs 072517Pharm1: 80 µl	22	09/09/17	< 80	176
	20172430118	Abs 071817Pharm: 50 µl & Abs 072517Pharm1: 50 µl	22	09/21/17	< 80	110
False Positive	20162020116	Abs 061516PHARM: 40 µl & Abs 060916PHARM: 40 µl	22.2	08/11/16	116	0
	20162020117	Abs 061516PHARM: 40 µl & Abs 060916PHARM: 40 µl	22.2	08/11/16	104	0
	20162230165	Abs 061516PHARM: 80 µl & Abs 060916PHARM: 80 µl	22.2	09/09/16	273	0
	20162230166	Abs 061516PHARM: 80 µl & Abs 060916PHARM: 80 µl	22.2	09/09/16	244	0
	20162800004	ERA 04281603: 40 µl & Abs 060916PHARM: 40 µl	22	10/29/16	E 182	0
	20162800005	ERA 04281603: 40 µl & Abs 060916PHARM: 40 µl	22	10/29/16	E 176	0
	20163630038	ERA 04281603: 100 µl & Abs 060916PHARM: 100 µl	22	01/19/17	E 341	0
	20163630039	ERA 04281603: 100 µl & Abs 060916PHARM: 100 µl	22	01/19/17	E 380	0
	20171020121	Abs 060916PHARM: 80 µl & Abs 061516PHARM: 80 µl	22	04/20/17	E 234	0
	20171380003	Abs 060916PHARM: 80 µl & Abs 061416: 80 µl	22	06/08/17	E 275	0
	20171660001	Abs 061416: 80 µl & Abs 060916PHARM: 80 µl	22	06/17/17	E 237	0
	20171870123	Abs 060916PHARM: 80 µl & Abs 061416: 80 µl	22	07/15/17	E 420	0
	20172280193	Abs 072517Pharm1: 50 µl & Abs 072517Pharm2: 50 µl	22	08/28/17	E 382	0
	20172560105	Abs 072517Pharm1: 20 µl & Abs 072517Pharm2: 20 µl	22	09/23/17	E 203	0
	20172700086	ERA 06281702: 50 µl & ERA 06281703: 50 µl	22	10/21/17	E 219	0
	20172980057	ERA 06281702: 20 µl & Abs 072517Pharm2: 20 µl	22	11/09/17	E 101	0

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

ALBUTEROL_(SALBUTAMOL)

Method: 2440 Testid: 67437LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

ALPRAZOLAM

Method: 2440 Testid: 68250LCM56

Link to Individual Chart

False Positive & Negative Listing for ALPRAZOLAM

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Positive	20160710221	ERA 0406-15-07A: 20 µl & ERA 0406-15-08: 20 µl	21.3	04/09/16	E 18.5	0

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

AMITRIPTYLINE

Method: 2440 Testid: 67522LCM56

Link to Individual Chart

False Positive & Negative Listing for AMITRIPTYLINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20171790209	ERA 04281604: 40 µl & Abs 061516PHARM: 40 µl	37	07/15/17	< 37	92.8

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

AMPHETAMINE

Method: 2440 Testid: 67461LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

ANTIPYRINE

Method: 2440 Testid: 67477LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

ATENOLOL

Method: 2440 Testid: 67502LCM56

Link to Individual Chart

False Positive & Negative Listing for ATENOLOL

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20170110050	Abs 060916PHARM: 40 µl & ERA 04281604: 40 µl	13	02/07/17	< 20.6	33.48
	20171870123	Abs 060916PHARM: 80 µl & Abs 061416: 80 µl	13	07/15/17	< 20	66.96

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

ATRAZINE

Method: 2440 Testid: 65065LCM56

Link to Individual Chart

False Positive & Negative Listing for ATRAZINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20170460062	Abs 061516PHARM: 40 µl & Crescent EN160610015: 40 µl	19	03/14/17	< 39.6	48.44
	20170460063	Abs 061516PHARM: 40 µl & Crescent EN160610015: 40 µl	19	03/14/17	< 35.8	48.44
	20170820004	ERA 04281603: 40 µl & Crescent EN160610015: 40 µl	19	04/07/17	< 34.3	48.4
	20170820005	ERA 04281603: 40 µl & Crescent EN160610015: 40 µl	19	04/07/17	< 41	48.4
False Positive	20162580143	Abs 061416: 80 µl & Crescent EN160610015: 80 µl	19.4	09/24/16	7.83	0
	20162580144	Crescent EN160610015: 80 µl & Abs 061416: 80 µl	19.4	09/24/16	8.19	0
	20162930164	Crescent EN160610015: 100 µl & ERA 04281604: 100 µl	19	11/03/16	4.42	0
	20163280002	Crescent EN160610015: 40 µl & Abs 061416: 40 µl	19	12/16/16	6.32	0
	20163280003	Crescent EN160610015: 40 µl & Abs 061416: 40 µl	19	12/16/16	8.33	0

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

BENZTROPINE

Method: 2440 Testid: 67997LCM56

Link to Individual Chart

False Positive & Negative Listing for BENZTROPINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20160980151	ERA 0406-15-07A: 20 µl & ERA 0406-15-08: 20 µl	24	04/27/16	< 24	36
	20163500006	ERA 04281604: 40 µl & Abs 061516PHARM: 40 µl	44	01/05/17	< 44	60.2
False Positive	20172430118	Abs 071817Pharm: 50 µl & Abs 072517Pharm1: 50 µl	44	09/21/17	E 2.3	0

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

BETAMETHASONE

Method: 2440 Testid: 67485LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

BUPROPION

Method: 2440 Testid: 67439LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

CAFFEINE

Method: 2440 Testid: 67440LCM56

Link to Individual Chart

False Positive & Negative Listing for CAFFEINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Positive	20162660011	ERA 04281604: 40 µl & Abs 061516PHARM: 40 µl	91	10/28/16	E 20.9	0

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

CARBAMAZEPINE

Method: 2440 Testid: 67441LCM56

Link to Individual Chart

False Positive & Negative Listing for CARBAMAZEPINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Positive	20162930164	Crescent EN160610015: 100 µl & ERA 04281604: 100 µl	11	11/03/16	0.27	0

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

CARISOPRODOL

Method: 2440 Testid: 67498LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

CHLORPHENIRAMINE

Method: 2440 Testid: 67497LCM56

Link to Individual Chart

False Positive & Negative Listing for CHLORPHENIRAMINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20161130022	Abs 050115: 40 µl & Abs 051315: 40 µl	4.68	04/27/16	< 4.68	14.04578
	20161130023	Abs 050115: 40 µl & Abs 051315: 40 µl	4.68	04/27/16	< 4.68	14.04578

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

CIMETIDINE

Method: 2440 Testid: 67442LCM56

Link to Individual Chart

False Positive & Negative Listing for CIMETIDINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20161260153	Abs 052215: 20 µl & ERA 0406-15-07A: 20 µl	27.8	05/11/16	< 27.8	41.76
	20161260154	Abs 052215: 20 µl & ERA 0406-15-07A: 20 µl	27.8	05/11/16	< 27.8	41.76
	20161880102	Abs 061416: 80 µl & Abs 061516PHARM: 80 µl	27.8	07/23/16	< 27.8	136.88
	20161880107	Abs 061416: 80 µl & Abs 061516PHARM: 80 µl	27.8	07/23/16	< 27.8	136.88
	20162380010	Abs 061416: 40 µl & ERA 04281603: 40 µl	27.8	09/17/16	< 27.8	68.44
	20162380011	Abs 061416: 40 µl & ERA 04281603: 40 µl	27.8	09/17/16	< 27.8	68.44
	20163280002	Crescent EN160610015: 40 µl & Abs 061416: 40 µl	42	12/16/16	< 42	68.44
	20163280003	Crescent EN160610015: 40 µl & Abs 061416: 40 µl	42	12/16/16	< 42	68.44
	20170320038	Abs 061416: 100 µl & ERA 04281603: 100 µl	42	02/07/17	< 42	171.1
	20170320039	Abs 061416: 100 µl & ERA 04281603: 100 µl	42	02/07/17	< 42	171.1
	20171380003	Abs 060916PHARM: 80 µl & Abs 061416: 80 µl	42	06/08/17	< 80	136.88
	20171660001	Abs 061416: 80 µl & Abs 060916PHARM: 80 µl	42	06/17/17	< 80	136.88
	20172280193	Abs 072517Pharm1: 50 µl & Abs 072517Pharm2: 50 µl	42	08/28/17	< 80	210
	20172510332	Abs 072517Pharm2: 80 µl & Abs 071817Pharm: 80 µl	42	09/21/17	< 80	336
	20172560105	Abs 072517Pharm1: 20 µl & Abs 072517Pharm2: 20 µl	42	09/23/17	< 80	84
	20172920004	Abs 072517Pharm2: 20 µl & ERA 06281704: 20 µl	42	11/08/17	< 42	84
	20172980057	ERA 06281702: 20 µl & Abs 072517Pharm2: 20 µl	42	11/09/17	< 42	84

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

CITALOPRAM

Method: 2440 Testid: 67505LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

CLONIDINE

Method: 2440 Testid: 67518LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

CODEINE

Method: 2440 Testid: 67443LCM56

Link to Individual Chart

False Positive & Negative Listing for CODEINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Positive	20171870123	Abs 060916PHARM: 80 µl & Abs 061416: 80 µl	88	07/15/17	18.8	0

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

COTININE

Method: 2440 Testid: 67444LCM56

Link to Individual Chart

False Positive & Negative Listing for COTININE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Positive	20162440106	Abs 061516PHARM: 40 µl & Crescent EN160610015: 40 µl	6.37	09/23/16	1.07	0
	20163150009	ERA 04281603: 80 µl & Crescent EN160610015: 80 µl	6.4	11/18/16	1.93	0

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

DEHYDRONIFEDIPINE

Method: 2440 Testid: 67445LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

DESMETHYLDILTIAZEM

Method: 2440 Testid: 67999LCM56

Link to Individual Chart

False Positive & Negative Listing for DESMETHYLDILTIAZEM

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20160840084	ERA 0406-15-09: 20 µl & ERA 0406-15-07A: 20 µl	12.4	04/09/16	< 12.4	18.54
	20170320038	Abs 061416: 100 µl & ERA 04281603: 100 µl	70	02/07/17	< 70	77.60001
	20170320039	Abs 061416: 100 µl & ERA 04281603: 100 µl	70	02/07/17	< 70	77.60001

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

DESVENLAFAXINE

Method: 2440 Testid: 68251LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

DEXTROMETHORPHAN

Method: 2440 Testid: 67468LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

DIAZEPAM_(VALIUM)

Method: 2440 Testid: 67499LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

DILTIAZEM

Method: 2440 Testid: 67519LCM56

Link to Individual Chart

False Positive & Negative Listing for DILTIAZEM

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Positive	20161130022	Abs 050115: 40 µl & Abs 051315: 40 µl	10.2	04/27/16	E 15.5	0

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

DIPHENHYDRAMINE

Method: 2440 Testid: 67447LCM56

Link to Individual Chart

False Positive & Negative Listing for DIPHENHYDRAMINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20161260153	Abs 052215: 20 µl & ERA 0406-15-07A: 20 µl	5.79	05/11/16	< 5.79	8.62
	20161260154	Abs 052215: 20 µl & ERA 0406-15-07A: 20 µl	5.79	05/11/16	< 5.79	8.62

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

DULOXETINE

Method: 2440 Testid: 67448LCM56

Link to Individual Chart

False Positive & Negative Listing for DULOXETINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20160840084	ERA 0406-15-09: 20 µl & ERA 0406-15-07A: 20 µl	36.6	04/09/16	< 36.6	55.8

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

ERYTHROMYCIN

Method: 2440 Testid: 67449LCM56

Link to Individual Chart

False Positive & Negative Listing for ERYTHROMYCIN

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20161260153	Abs 052215: 20 µl & ERA 0406-15-07A: 20 µl	53.1	05/11/16	< 53.1	79.2
	20161260154	Abs 052215: 20 µl & ERA 0406-15-07A: 20 µl	53.1	05/11/16	< 53.1	79.2
	20161740257	Abs 060916PHARM: 80 µl & Abs 061416: 80 µl	53.1	07/22/16	< 53.1	264.4
	20161740283	Abs 060916PHARM: 80 µl & Abs 061416: 80 µl	53.1	07/22/16	< 53.1	264.4
	20161880102	Abs 061416: 80 µl & Abs 061516PHARM: 80 µl	53.1	07/23/16	< 53.1	264.4
	20161880107	Abs 061416: 80 µl & Abs 061516PHARM: 80 µl	53.1	07/23/16	< 53.1	264.4
	20162100012	Abs 060916PHARM: 40 µl & Abs 061416: 40 µl	53.1	08/16/16	< 80	132.2
	20162100013	Abs 060916PHARM: 40 µl & Abs 061416: 40 µl	53.1	08/16/16	< 80	132.2
	20162150208	Abs 061416: 40 µl & Abs 061516PHARM: 40 µl	53.1	08/17/16	< 80	132.2
	20162150209	Abs 061416: 40 µl & Abs 061516PHARM: 40 µl	53.1	08/17/16	< 80	132.2
	20162380010	Abs 061416: 40 µl & ERA 04281603: 40 µl	53.1	09/17/16	< 53.1	132.2
	20162380011	Abs 061416: 40 µl & ERA 04281603: 40 µl	53.1	09/17/16	< 53.1	132.2
	20162580143	Abs 061416: 80 µl & Crescent EN160610015: 80 µl	53.1	09/24/16	< 80	264.4
	20162580144	Crescent EN160610015: 80 µl & Abs 061416: 80 µl	53.1	09/24/16	< 80	264.4
	20163280002	Crescent EN160610015: 40 µl & Abs 061416: 40 µl	80	12/16/16	< 80	132.2
	20163280003	Crescent EN160610015: 40 µl & Abs 061416: 40 µl	80	12/16/16	< 80	132.2
	20170110050	Abs 060916PHARM: 40 µl & ERA 04281604: 40 µl	80	02/07/17	< 80	133.2
	20170110051	Abs 060916PHARM: 40 µl & ERA 04281604: 40 µl	80	02/07/17	< 80	133.2
	20170320038	Abs 061416: 100 µl & ERA 04281603: 100 µl	80	02/07/17	< 80	330.5
	20170320039	Abs 061416: 100 µl & ERA 04281603: 100 µl	80	02/07/17	< 80	330.5
	20171230083	Abs 061416: 40 µl & ERA 04281603: 40 µl	80	05/11/17	< 80	132.2
	20171300148	Crescent EN160610015: 40 µl & ERA 04281604: 40 µl	80	06/07/17	< 80	133.2
	20171380003	Abs 060916PHARM: 80 µl & Abs 061416: 80 µl	80	06/08/17	< 80	264.4
	20171660001	Abs 061416: 80 µl & Abs 060916PHARM: 80 µl	80	06/17/17	< 80	264.4
	20171870123	Abs 060916PHARM: 80 µl & Abs 061416: 80 µl	80	07/15/17	< 80	264.4
	20172150194	Abs 072517Pharm2: 50 µl & Abs 071817Pharm: 50 µl	80	08/25/17	< 200	400.5
	20172230004	Abs 072517Pharm1: 50 µl & Abs 071817Pharm: 50 µl	80	08/26/17	< 200	400.5
	20172430118	Abs 071817Pharm: 50 µl & Abs 072517Pharm1: 50 µl	80	09/21/17	< 200	400.5
	20172510332	Abs 072517Pharm2: 80 µl & Abs 071817Pharm: 80 µl	80	09/21/17	< 200	640.8

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

EZETIMIBE

Method: 2440 Testid: 67487LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

FADROZOLE

Method: 2440 Testid: 68012LCM56

Link to Individual Chart

False Positive & Negative Listing for FADROZOLE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20171300148	Crescent EN160610015: 40 µl & ERA 04281604: 40 µl	13	06/07/17	< 13	18.44

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

FAMOTIDINE

Method: 2440 Testid: 68000LCM56

Link to Individual Chart

False Positive & Negative Listing for FAMOTIDINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20160980151	ERA 0406-15-07A: 20 µl & ERA 0406-15-08: 20 µl	10.7	04/27/16	< 10.7	16.02
	20161130022	Abs 050115: 40 µl & Abs 051315: 40 µl	10.7	04/27/16	< 10.7	32.04
	20161130023	Abs 050115: 40 µl & Abs 051315: 40 µl	10.7	04/27/16	< 10.7	32.04
	20163630038	ERA 04281603: 100 µl & Abs 060916PHARM: 100 µl	34	01/19/17	< 34	67.1
	20163630039	ERA 04281603: 100 µl & Abs 060916PHARM: 100 µl	34	01/19/17	< 34	67.1
	20171020121	Abs 060916PHARM: 80 µl & Abs 061516PHARM: 80 µl	34	04/20/17	< 34	53.68
	20171660001	Abs 061416: 80 µl & Abs 060916PHARM: 80 µl	34	06/17/17	< 34	53.68
	20171870123	Abs 060916PHARM: 80 µl & Abs 061416: 80 µl	34	07/15/17	< 40	53.68
	20172430118	Abs 071817Pharm: 50 µl & Abs 072517Pharm1: 50 µl	34	09/21/17	< 80	170

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

FENOFIBRATE

Method: 2440 Testid: 67489LCM56

Link to Individual Chart

False Positive & Negative Listing for FENOFIBRATE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20161260153	Abs 052215: 20 µl & ERA 0406-15-07A: 20 µl	6.28	05/11/16	< 6.28	9.44
	20161260154	Abs 052215: 20 µl & ERA 0406-15-07A: 20 µl	6.28	05/11/16	< 6.28	9.44
	20162150208	Abs 061416: 40 µl & Abs 061516PHARM: 40 µl	6.28	08/17/16	< 6.45	15.64
	20162150209	Abs 061416: 40 µl & Abs 061516PHARM: 40 µl	6.28	08/17/16	< 6.28	15.64
	20163070101	ERA 04281604: 80 µl & ERA 04281603: 80 µl	14	11/18/16	< 14	31.44
	20163070102	ERA 04281603: 80 µl & ERA 04281604: 80 µl	14	11/18/16	< 14	31.44
	20163150009	ERA 04281603: 80 µl & Crescent EN160610015: 80 µl	14	11/18/16	< 14	31.44

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

FEXOFENADINE

Method: 2440 Testid: 67510LCM56

Link to Individual Chart

False Positive & Negative Listing for FEXOFENADINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20160840084	ERA 0406-15-09: 20 µl & ERA 0406-15-07A: 20 µl	19.9	04/09/16	< 20	30

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

FLUCONAZOLE

Method: 2440 Testid: 67478LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

FLUOXETINE

Method: 2440 Testid: 67450LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

FLUTICASONE_PROPIONATE

Method: 2440 Testid: 67529LCM56

Link to Individual Chart

False Positive & Negative Listing for FLUTICASONE_PROPIONATE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20161260153	Abs 052215: 20 µl & ERA 0406-15-07A: 20 µl	4.62	05/11/16	< 4.62	6.92

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

FLUVOXAMINE

Method: 2440 Testid: 67521LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

GLIPIZIDE

Method: 2440 Testid: 68001LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

GLYBURIDE

Method: 2440 Testid: 68002LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

HYDROCODONE

Method: 2440 Testid: 67506LCM56

Link to Individual Chart

False Positive & Negative Listing for HYDROCODONE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20170680003	Crescent EN160610015: 40 µl & ERA 04281604: 40 µl	10	03/14/17	< 26.3	26.4
	20170680004	Crescent EN160610015: 40 µl & ERA 04281604: 40 µl	10	03/14/17	< 25.5	26.4
	20171300148	Crescent EN160610015: 40 µl & ERA 04281604: 40 µl	10	06/07/17	< 20	26.4

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

HYDROCORTISONE

Method: 2440 Testid: 67459LCM56

Link to Individual Chart

False Positive & Negative Listing for HYDROCORTISONE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20160840084	ERA 0406-15-09: 20 µl & ERA 0406-15-07A: 20 µl	147	04/09/16	< 200	218
	20161260154	Abs 052215: 20 µl & ERA 0406-15-07A: 20 µl	147	05/11/16	< 175	221.22

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

HYDROXYZINE

Method: 2440 Testid: 68005LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

IMINOSTILBENE

Method: 2440 Testid: 67481LCM56

Link to Individual Chart

False Positive & Negative Listing for IMINOSTILBENE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20172920004	Abs 072517Pharm2: 20 µl & ERA 06281704: 20 µl	145	11/08/17	< 145	290
	20172980057	ERA 06281702: 20 µl & Abs 072517Pharm2: 20 µl	145	11/09/17	< 145	290

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

KETOCONAZOLE

Method: 2440 Testid: 68014LCM56

Link to Individual Chart

False Positive & Negative Listing for KETOCONAZOLE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20170740060	ERA 04281603: 40 µl & ERA 04281604: 40 µl	113	04/06/17	< 113	282.4

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

LAMIVUDINE

Method: 2440 Testid: 68018LCM56

Link to Individual Chart

False Positive & Negative Listing for LAMIVUDINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20160710221	ERA 0406-15-07A: 20 µl & ERA 0406-15-08: 20 µl	16.1	04/09/16	< 20	24.4
	20161130022	Abs 050115: 40 µl & Abs 051315: 40 µl	16.1	04/27/16	< 16.1	48.04
	20161130023	Abs 050115: 40 µl & Abs 051315: 40 µl	16.1	04/27/16	< 16.1	48.04
	20163500006	ERA 04281604: 40 µl & Abs 061516PHARM: 40 µl	16	01/05/17	< 28.7	40.04
	20163500007	ERA 04281604: 40 µl & Abs 061516PHARM: 40 µl	16	01/05/17	< 24.1	40.04
	20170460063	Abs 061516PHARM: 40 µl & Crescent EN160610015: 40 µl	16	03/14/17	< 20	40.04
	20171020121	Abs 060916PHARM: 80 µl & Abs 061516PHARM: 80 µl	16	04/20/17	< 16	80.08
	20171440229	Crescent EN160610015: 40 µl & Abs 061516PHARM: 40 µl	16	06/18/17	< 20	40.04
	20171790209	ERA 04281604: 40 µl & Abs 061516PHARM: 40 µl	16	07/15/17	< 20	40.04
	20172020156	ERA 04281604: 40 µl & Abs 061516PHARM: 40 µl	16	08/11/17	< 20	40.04

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

LIDOCAINE

Method: 2440 Testid: 67462LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

LOPERAMIDE

Method: 2440 Testid: 67515LCM56

Link to Individual Chart

False Positive & Negative Listing for LOPERAMIDE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20160840084	ERA 0406-15-09: 20 µl & ERA 0406-15-07A: 20 µl	11.5	04/09/16	< 11.5	17.36
	20161260153	Abs 052215: 20 µl & ERA 0406-15-07A: 20 µl	11.5	05/11/16	< 11.5	17.22
	20161260154	Abs 052215: 20 µl & ERA 0406-15-07A: 20 µl	11.5	05/11/16	< 11.5	17.22
	20162020116	Abs 061516PHARM: 40 µl & Abs 060916PHARM: 40 µl	11.5	08/11/16	< 12.5	28.84
	20162020117	Abs 061516PHARM: 40 µl & Abs 060916PHARM: 40 µl	11.5	08/11/16	< 11.5	28.84

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

LORATADINE

Method: 2440 Testid: 67488LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

LORAZEPAM

Method: 2440 Testid: 67470LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

MEPROBAMATE

Method: 2440 Testid: 67464LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

METAXALONE

Method: 2440 Testid: 67504LCM56

Link to Individual Chart

False Positive & Negative Listing for METAXALONE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.
False Positive	20160980151	ERA 0406-15-07A: 20 µl & ERA 0406-15-08: 20 µl	15.6	04/27/16	E 7.06
	20161260154	Abs 052215: 20 µl & ERA 0406-15-07A: 20 µl	15.6	05/11/16	E 13.6
	20162380010	Abs 061416: 40 µl & ERA 04281603: 40 µl	15.6	09/17/16	E 4.81
	20162380011	Abs 061416: 40 µl & ERA 04281603: 40 µl	15.6	09/17/16	E 5.25
	20163630038	ERA 04281603: 100 µl & Abs 060916PHARM: 100 µl	16	01/19/17	E 25.2
	20163630039	ERA 04281603: 100 µl & Abs 060916PHARM: 100 µl	16	01/19/17	E 19.4

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

METFORMIN

Method: 2440 Testid: 67492LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

METHADONE

Method: 2440 Testid: 67500LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

METHOCARBAMOL

Method: 2440 Testid: 67501LCM56

Link to Individual Chart

False Positive & Negative Listing for METHOCARBAMOL

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Positive	20162100012	Abs 060916PHARM: 40 µl & Abs 061416: 40 µl	8.72	08/16/16	E 11.1	0

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

METHOTREXATE

Method: 2440 Testid: 67525LCM56

Link to Individual Chart

False Positive & Negative Listing for METHOTREXATE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20160980151	ERA 0406-15-07A: 20 µl & ERA 0406-15-08: 20 µl	52.4	04/27/16	< 52.4	78
	20161260153	Abs 052215: 20 µl & ERA 0406-15-07A: 20 µl	52.4	05/11/16	< 52.4	78
	20161260154	Abs 052215: 20 µl & ERA 0406-15-07A: 20 µl	52.4	05/11/16	< 52.4	78
	20170110050	Abs 060916PHARM: 40 µl & ERA 04281604: 40 µl	52	02/07/17	< 80	132.48
	20170110051	Abs 060916PHARM: 40 µl & ERA 04281604: 40 µl	52	02/07/17	< 90.5	132.48
	20170460062	Abs 061516PHARM: 40 µl & Crescent EN160610015: 40 µl	52	03/14/17	< 80	133.2
	20170460063	Abs 061516PHARM: 40 µl & Crescent EN160610015: 40 µl	52	03/14/17	< 80	133.2
	20171300148	Crescent EN160610015: 40 µl & ERA 04281604: 40 µl	52	06/07/17	< 80	133.2
	20172560105	Abs 072517Pharm1: 20 µl & Abs 072517Pharm2: 20 µl	52	09/23/17	< 102	104
	20172700086	ERA 06281702: 50 µl & ERA 06281703: 50 µl	52	10/21/17	< 80	258
	20172780021	ERA 06281703: 20 µl & ERA 06281704: 20 µl	52	10/22/17	< 80	103.2

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

METHYL-1H-BENZOTRIAZOLE

Method: 2440 Testid: 67514LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

METOPROLOL

Method: 2440 Testid: 67523LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

MORPHINE

Method: 2440 Testid: 67458LCM56

Link to Individual Chart

False Positive & Negative Listing for MORPHINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20161130022	Abs 050115: 40 µl & Abs 051315: 40 µl	14	04/27/16	< 14	42.16
	20161130023	Abs 050115: 40 µl & Abs 051315: 40 µl	14	04/27/16	< 14	42.16

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

NADALOL

Method: 2440 Testid: 68006LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

NEVIRAPINE

Method: 2440 Testid: 68017LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

NICOTINE

Method: 2440 Testid: 67493LCM56

Link to Individual Chart

False Positive & Negative Listing for NICOTINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20160710221	ERA 0406-15-07A: 20 µl & ERA 0406-15-08: 20 µl	57.8	04/09/16	< 57.8	86.6
	20171580165	ERA 04281604: 80 µl & ERA 04281603: 80 µl	58	06/17/17	< 95.5	288
	20171660001	Abs 061416: 80 µl & Abs 060916PHARM: 80 µl	58	06/17/17	< 80	288.56

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

NIZATIDINE

Method: 2440 Testid: 67479LCM56

Link to Individual Chart

False Positive & Negative Listing for NIZATIDINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20161260153	Abs 052215: 20 µl & ERA 0406-15-07A: 20 µl	19	05/11/16	< 19	28.48
	20161260154	Abs 052215: 20 µl & ERA 0406-15-07A: 20 µl	19	05/11/16	< 19	28.48
	20162020116	Abs 061516PHARM: 40 µl & Abs 060916PHARM: 40 µl	19	08/11/16	< 20	48.16
	20162020117	Abs 061516PHARM: 40 µl & Abs 060916PHARM: 40 µl	19	08/11/16	< 20	48.16
	20163630038	ERA 04281603: 100 µl & Abs 060916PHARM: 100 µl	80	01/19/17	< 80	120.4
	20163630039	ERA 04281603: 100 µl & Abs 060916PHARM: 100 µl	80	01/19/17	< 80	120.4
	20171020121	Abs 060916PHARM: 80 µl & Abs 061516PHARM: 80 µl	80	04/20/17	< 80	96.32
	20171380003	Abs 060916PHARM: 80 µl & Abs 061416: 80 µl	80	06/08/17	< 80	96.32
	20171660001	Abs 061416: 80 µl & Abs 060916PHARM: 80 µl	80	06/17/17	< 80	96.32
	20171870123	Abs 060916PHARM: 80 µl & Abs 061416: 80 µl	80	07/15/17	< 80	96.32
	20172430118	Abs 071817Pharm: 50 µl & Abs 072517Pharm1: 50 µl	80	09/21/17	< 80	399
	20172560105	Abs 072517Pharm1: 20 µl & Abs 072517Pharm2: 20 µl	80	09/23/17	< 80	159.6

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

NORDIAZEPAM

Method: 2440 Testid: 68252LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

NORETHINDRONE

Method: 2440 Testid: 67434LCM56

Link to Individual Chart

False Positive & Negative Listing for NORETHINDRONE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20171440229	Crescent EN160610015: 40 µl & Abs 061516PHARM: 40 µl	20	06/18/17	< 20	27.64

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

NORFLUOXETINE

Method: 2440 Testid: 67451LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

NORSERTRALINE

Method: 2440 Testid: 67532LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

NORVERAPAMIL

Method: 2440 Testid: 68007LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

OMEPRAZOLE_+_ESOMEPRAZOLE

Method: 2440 Testid: 67512LCM56

Link to Individual Chart

False Positive & Negative Listing for OMEPRAZOLE_+_ESOMEPRAZOLE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20162020116	Abs 061516PHARM: 40 µl & Abs 060916PHARM: 40 µl	5.62	08/11/16	< 5.62	14.04

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

OSELTAMIVIR

Method: 2440 Testid: 67511LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

OXAZEPAM

Method: 2440 Testid: 67469LCM56

Link to Individual Chart

False Positive & Negative Listing for OXAZEPAM

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20162580143	Abs 061416: 80 µl & Crescent EN160610015: 80 µl	140	09/24/16	< 140	696.8

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

OXYCODONE

Method: 2440 Testid: 67495LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

PAROXETINE

Method: 2440 Testid: 67527LCM56

Link to Individual Chart

False Positive & Negative Listing for PAROXETINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20160710221	ERA 0406-15-07A: 20 µl & ERA 0406-15-08: 20 µl	20.6	04/09/16	< 20.6	31.2
	20160840084	ERA 0406-15-09: 20 µl & ERA 0406-15-07A: 20 µl	20.6	04/09/16	< 20.6	31.2
	20161260153	Abs 052215: 20 µl & ERA 0406-15-07A: 20 µl	20.6	05/11/16	< 20.6	31.2

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

PENCICLOVIR

Method: 2440 Testid: 68021LCM56

Link to Individual Chart

False Positive & Negative Listing for PENCICLOVIR

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20163500006	ERA 04281604: 40 µl & Abs 061516PHARM: 40 µl	80	01/05/17	< 80	99.6
	20163500007	ERA 04281604: 40 µl & Abs 061516PHARM: 40 µl	80	01/05/17	< 80	99.6
	20170110050	Abs 060916PHARM: 40 µl & ERA 04281604: 40 µl	80	02/07/17	< 80	99.6
	20170110051	Abs 060916PHARM: 40 µl & ERA 04281604: 40 µl	80	02/07/17	< 80	99.6
	20170680003	Crescent EN160610015: 40 µl & ERA 04281604: 40 µl	80	03/14/17	< 80	99.6
	20171300148	Crescent EN160610015: 40 µl & ERA 04281604: 40 µl	80	06/07/17	< 80	99.6
	20171790209	ERA 04281604: 40 µl & Abs 061516PHARM: 40 µl	80	07/15/17	< 80	99.6
	20172020156	ERA 04281604: 40 µl & Abs 061516PHARM: 40 µl	80	08/11/17	< 80	99.6

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

PENTOXIFYLLINE

Method: 2440 Testid: 67480LCM56

Link to Individual Chart

False Positive & Negative Listing for PENTOXIFYLLINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20160840084	ERA 0406-15-09: 20 µl & ERA 0406-15-07A: 20 µl	9.35	04/09/16	< 9.35	14.04

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

PHENAZOPYRIDINE

Method: 2440 Testid: 68008LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

PHENYTOIN

Method: 2440 Testid: 67466LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

PIPERONYL_BUTOXIDE

Method: 2440 Testid: 67435LCM56

Link to Individual Chart

False Positive & Negative Listing for PIPERONYL_BUTOXIDE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20161260153	Abs 052215: 20 µl & ERA 0406-15-07A: 20 µl	3.07	05/11/16	< 3.07	4.56
	20161260154	Abs 052215: 20 µl & ERA 0406-15-07A: 20 µl	3.07	05/11/16	< 3.07	4.56

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

PREDNISOLONE

Method: 2440 Testid: 67483LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

PREDNISONE

Method: 2440 Testid: 67467LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

PROMETHAZINE

Method: 2440 Testid: 67524LCM56

Link to Individual Chart

False Positive & Negative Listing for PROMETHAZINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20161130022	Abs 050115: 40 µl & Abs 051315: 40 µl	50	04/27/16	< 80	148.08
	20161130023	Abs 050115: 40 µl & Abs 051315: 40 µl	50	04/27/16	< 80	148.08
	20161740257	Abs 060916PHARM: 80 µl & Abs 061416: 80 µl	50	07/22/16	< 50	248.16
	20161740283	Abs 060916PHARM: 80 µl & Abs 061416: 80 µl	50	07/22/16	< 50	248.16
	20162020116	Abs 061516PHARM: 40 µl & Abs 060916PHARM: 40 µl	50	08/11/16	< 50	124.08
	20162020117	Abs 061516PHARM: 40 µl & Abs 060916PHARM: 40 µl	50	08/11/16	< 50	124.08
	20162100012	Abs 060916PHARM: 40 µl & Abs 061416: 40 µl	50	08/16/16	< 80	124.08
	20162100013	Abs 060916PHARM: 40 µl & Abs 061416: 40 µl	50	08/16/16	< 80	124.08
	20162230165	Abs 061516PHARM: 80 µl & Abs 060916PHARM: 80 µl	50	09/09/16	< 50	248.16
	20162230166	Abs 061516PHARM: 80 µl & Abs 060916PHARM: 80 µl	50	09/09/16	< 50	248.16
	20162300274	Abs 060916PHARM: 40 µl & ERA 04281604: 40 µl	50	09/10/16	< 50	124.08
	20162300275	Abs 060916PHARM: 40 µl & ERA 04281604: 40 µl	50	09/10/16	< 50	124.08
	20162440106	Abs 061516PHARM: 40 µl & Crescent EN160610015: 40 µl	50	09/23/16	< 50	124
	20162440107	Abs 061516PHARM: 40 µl & Crescent EN160610015: 40 µl	50	09/23/16	< 50	124
	20162580143	Abs 061416: 80 µl & Crescent EN160610015: 80 µl	50	09/24/16	< 50	248
	20162580144	Crescent EN160610015: 80 µl & Abs 061416: 80 µl	50	09/24/16	< 50	248
	20162800004	ERA 04281603: 40 µl & Abs 060916PHARM: 40 µl	80	10/29/16	< 80	124.08
	20162800005	ERA 04281603: 40 µl & Abs 060916PHARM: 40 µl	80	10/29/16	< 80	124.08
	20162930164	Crescent EN160610015: 100 µl & ERA 04281604: 100 µl	80	11/03/16	< 200	310
	20162930165	Crescent EN160610015: 100 µl & ERA 04281604: 100 µl	80	11/03/16	< 200	310
	20163150008	ERA 04281603: 80 µl & Crescent EN160610015: 80 µl	80	11/18/16	< 80	248
	20163150009	ERA 04281603: 80 µl & Crescent EN160610015: 80 µl	80	11/18/16	< 80	248
	20163280002	Crescent EN160610015: 40 µl & Abs 061416: 40 µl	80	12/16/16	< 80	124
	20163280003	Crescent EN160610015: 40 µl & Abs 061416: 40 µl	80	12/16/16	< 80	124
	20163630038	ERA 04281603: 100 µl & Abs 060916PHARM: 100 µl	80	01/19/17	< 80	310.2
	20163630039	ERA 04281603: 100 µl & Abs 060916PHARM: 100 µl	80	01/19/17	< 80	310.2
	20170110050	Abs 060916PHARM: 40 µl & ERA 04281604: 40 µl	80	02/07/17	< 80	124.08
	20170110051	Abs 060916PHARM: 40 µl & ERA 04281604: 40 µl	80	02/07/17	< 80	124.08
	20170460062	Abs 061516PHARM: 40 µl & Crescent EN160610015: 40 µl	80	03/14/17	< 80	124
	20170460063	Abs 061516PHARM: 40 µl & Crescent EN160610015: 40 µl	80	03/14/17	< 80	124
	20170680003	Crescent EN160610015: 40 µl & ERA 04281604: 40 µl	80	03/14/17	< 80	124
	20170680004	Crescent EN160610015: 40 µl & ERA 04281604: 40 µl	80	03/14/17	< 80	124
	20170820004	ERA 04281603: 40 µl & Crescent EN160610015: 40 µl	80	04/07/17	< 80	124
	20170820005	ERA 04281603: 40 µl & Crescent EN160610015: 40 µl	80	04/07/17	< 80	124
	20171020121	Abs 060916PHARM: 80 µl & Abs 061516PHARM: 80 µl	80	04/20/17	< 80	248.16
	20171380003	Abs 060916PHARM: 80 µl & Abs 061416: 80 µl	80	06/08/17	< 140	248.16
	20171660001	Abs 061416: 80 µl & Abs 060916PHARM: 80 µl	80	06/17/17	< 140	248.16
	20171720142	Crescent EN160610015: 80 µl & ERA 04281603: 80 µl	80	07/14/17	< 80	248
	20171870123	Abs 060916PHARM: 80 µl & Abs 061416: 80 µl	80	07/15/17	< 80	248.16
	20171940003	Crescent EN160610015: 80 µl & ERA 04281603: 80 µl	80	08/10/17	< 200	248
	20172070148	Abs 060916PHARM: 20 µl & Abs 071817Pharm: 20 µl	80	08/11/17	< 200	222.24
	20172150194	Abs 072517Pharm2: 50 µl & Abs 071817Pharm: 50 µl	80	08/25/17	< 80	400.5
	20172230004	Abs 072517Pharm1: 50 µl & Abs 071817Pharm: 50 µl	80	08/26/17	< 80	400.5
	20172370004	Abs 071817Pharm: 80 µl & Abs 072517Pharm1: 80 µl	80	09/09/17	< 80	640.8
	20172430118	Abs 071817Pharm: 50 µl & Abs 072517Pharm1: 50 µl	80	09/21/17	< 80	400.5
	20172510332	Abs 072517Pharm2: 80 µl & Abs 071817Pharm: 80 µl	80	09/21/17	< 80	640.8

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

PROPOXYPHENE

Method: 2440 Testid: 68009LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

PROPRANOLOL

Method: 2440 Testid: 67516LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

PSEUDOEPHEDRINE+EPHEDRINE

Method: 2440 Testid: 67460LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

QUININE

Method: 2440 Testid: 68011LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

RALOXIFENE

Method: 2440 Testid: 67530LCM56

Link to Individual Chart

False Positive & Negative Listing for RALOXIFENE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20160840084	ERA 0406-15-09: 20 µl & ERA 0406-15-07A: 20 µl	9.72	04/09/16	< 9.72	14.76

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

RANITIDINE

Method: 2440 Testid: 67452LCM56

Link to Individual Chart

False Positive & Negative Listing for RANITIDINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20161130022	Abs 050115: 40 µl & Abs 051315: 40 µl	192	04/27/16	< 200	578.32
	20161130023	Abs 050115: 40 µl & Abs 051315: 40 µl	192	04/27/16	< 200	578.32
	20161880102	Abs 061416: 80 µl & Abs 061516PHARM: 80 µl	192	07/23/16	< 192	963.84
	20161880107	Abs 061416: 80 µl & Abs 061516PHARM: 80 µl	192	07/23/16	< 192	963.84
	20162020116	Abs 061516PHARM: 40 µl & Abs 060916PHARM: 40 µl	192	08/11/16	< 192	481.92
	20162020117	Abs 061516PHARM: 40 µl & Abs 060916PHARM: 40 µl	192	08/11/16	< 192	481.92
	20162440106	Abs 061516PHARM: 40 µl & Crescent EN160610015: 40 µl	192	09/23/16	< 192	481.92
	20162440107	Abs 061516PHARM: 40 µl & Crescent EN160610015: 40 µl	192	09/23/16	< 192	481.92
	20163500006	ERA 04281604: 40 µl & Abs 061516PHARM: 40 µl	192	01/05/17	< 192	481.92
	20163500007	ERA 04281604: 40 µl & Abs 061516PHARM: 40 µl	192	01/05/17	< 192	481.92
	20170460062	Abs 061516PHARM: 40 µl & Crescent EN160610015: 40 µl	192	03/14/17	< 192	481.92
	20170460063	Abs 061516PHARM: 40 µl & Crescent EN160610015: 40 µl	192	03/14/17	< 192	481.92
	20170820004	ERA 04281603: 40 µl & Crescent EN160610015: 40 µl	192	04/07/17	< 200	480
	20171020121	Abs 060916PHARM: 80 µl & Abs 061516PHARM: 80 µl	192	04/20/17	< 200	963.84
	20171440229	Crescent EN160610015: 40 µl & Abs 061516PHARM: 40 µl	192	06/18/17	< 192	481.92
	20171790209	ERA 04281604: 40 µl & Abs 061516PHARM: 40 µl	192	07/15/17	< 192	481.92
	20172020156	ERA 04281604: 40 µl & Abs 061516PHARM: 40 µl	192	08/11/17	< 200	481.92
	20172280193	Abs 072517Pharm1: 50 µl & Abs 072517Pharm2: 50 µl	192	08/28/17	< 200	960
	20172920004	Abs 072517Pharm2: 20 µl & ERA 06281704: 20 µl	192	11/08/17	< 192	384
	20172980057	ERA 06281702: 20 µl & Abs 072517Pharm2: 20 µl	192	11/09/17	< 192	384

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

SERTRALINE

Method: 2440 Testid: 67528LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

SITAGLIPTIN

Method: 2440 Testid: 67531LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

SULFADIMETHOXINE

Method: 2440 Testid: 67503LCM56

Link to Individual Chart

False Positive & Negative Listing for SULFADIMETHOXINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Positive	20171940003	Crescent EN160610015: 80 µl & ERA 04281603: 80 µl	65	08/10/17	3.6	0

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

SULFAMETHIZOLE

Method: 2440 Testid: 67476LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

SULFAMETHOXAZOLE

Method: 2440 Testid: 67454LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

TAMOXIFEN

Method: 2440 Testid: 68015LCM56

Link to Individual Chart

False Positive & Negative Listing for TAMOXIFEN

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20160710221	ERA 0406-15-07A: 20 µl & ERA 0406-15-08: 20 µl	80	04/09/16	< 80	119.6
	20161130022	Abs 050115: 40 µl & Abs 051315: 40 µl	80	04/27/16	< 200	240.08
	20161130023	Abs 050115: 40 µl & Abs 051315: 40 µl	80	04/27/16	< 200	240.08
	20161740283	Abs 060916PHARM: 80 µl & Abs 061416: 80 µl	80	07/22/16	< 80	402.56
	20161880102	Abs 061416: 80 µl & Abs 061516PHARM: 80 µl	80	07/23/16	< 80	402.56
	20162100012	Abs 060916PHARM: 40 µl & Abs 061416: 40 µl	80	08/16/16	< 200	201.28
	20162100013	Abs 060916PHARM: 40 µl & Abs 061416: 40 µl	80	08/16/16	< 200	201.28
	20162150208	Abs 061416: 40 µl & Abs 061516PHARM: 40 µl	80	08/17/16	< 80	201.28
	20162150209	Abs 061416: 40 µl & Abs 061516PHARM: 40 µl	80	08/17/16	< 200	201.28
	20162300274	Abs 060916PHARM: 40 µl & ERA 04281604: 40 µl	80	09/10/16	< 80	200.4
	20162300275	Abs 060916PHARM: 40 µl & ERA 04281604: 40 µl	80	09/10/16	< 80	200.4
	20162380010	Abs 061416: 40 µl & ERA 04281603: 40 µl	80	09/17/16	< 200	201.28
	20162380011	Abs 061416: 40 µl & ERA 04281603: 40 µl	80	09/17/16	< 200	201.28
	20162580143	Abs 061416: 80 µl & Crescent EN160610015: 80 µl	80	09/24/16	< 200	402.56
	20162580144	Crescent EN160610015: 80 µl & Abs 061416: 80 µl	80	09/24/16	< 200	402.56
	20162930164	Crescent EN160610015: 100 µl & ERA 04281604: 100 µl	270	11/03/16	< 270	501
	20162930165	Crescent EN160610015: 100 µl & ERA 04281604: 100 µl	270	11/03/16	< 270	501
	20163070101	ERA 04281604: 80 µl & ERA 04281603: 80 µl	270	11/18/16	< 270	400.8
	20163070102	ERA 04281603: 80 µl & ERA 04281604: 80 µl	270	11/18/16	< 270	400.8
	20170320038	Abs 061416: 100 µl & ERA 04281603: 100 µl	270	02/07/17	< 270	503.2
	20170320039	Abs 061416: 100 µl & ERA 04281603: 100 µl	270	02/07/17	< 270	503.2
	20171380003	Abs 060916PHARM: 80 µl & Abs 061416: 80 µl	270	06/08/17	< 270	402.56
	20171580165	ERA 04281604: 80 µl & ERA 04281603: 80 µl	270	06/17/17	< 270	400.8
	20171660001	Abs 061416: 80 µl & Abs 060916PHARM: 80 µl	270	06/17/17	< 270	402.56
	20171870123	Abs 060916PHARM: 80 µl & Abs 061416: 80 µl	270	07/15/17	< 270	402.56
	20172070148	Abs 060916PHARM: 20 µl & Abs 071817Pharm: 20 µl	270	08/11/17	< 270	540
	20172150194	Abs 072517Pharm2: 50 µl & Abs 071817Pharm: 50 µl	270	08/25/17	< 270	1350
	20172230004	Abs 072517Pharm1: 50 µl & Abs 071817Pharm: 50 µl	270	08/26/17	< 270	1350
	20172370004	Abs 071817Pharm: 80 µl & Abs 072517Pharm1: 80 µl	270	09/09/17	< 270	2160
	20172780021	ERA 06281703: 20 µl & ERA 06281704: 20 µl	270	10/22/17	< 270	540
	20172860030	ERA 06281704: 20 µl & Abs 072517Pharm1: 20 µl	270	11/08/17	< 270	540
	20172920004	Abs 072517Pharm2: 20 µl & ERA 06281704: 20 µl	270	11/08/17	< 270	540

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

TEMAZEPAM

Method: 2440 Testid: 67471LCM56

Link to Individual Chart

False Positive & Negative Listing for TEMAZEPAM

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20170320038	Abs 061416: 100 µl & ERA 04281603: 100 µl	18	02/07/17	< 80	120.4
	20170320039	Abs 061416: 100 µl & ERA 04281603: 100 µl	18	02/07/17	< 80	120.4
	20172560105	Abs 072517Pharm1: 20 µl & Abs 072517Pharm2: 20 µl	18	09/23/17	< 20.8	36

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

THEOPHYLLINE

Method: 2440 Testid: 67494LCM56

Link to Individual Chart

False Positive & Negative Listing for THEOPHYLLINE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20162020116	Abs 061516PHARM: 40 µl & Abs 060916PHARM: 40 µl	41.5	08/11/16	< 80	104.44
	20162020117	Abs 061516PHARM: 40 µl & Abs 060916PHARM: 40 µl	41.5	08/11/16	< 95.8	104.44
False Positive	20162800004	ERA 04281603: 40 µl & Abs 060916PHARM: 40 µl	80	10/29/16	E 64.1	0
	20162800005	ERA 04281603: 40 µl & Abs 060916PHARM: 40 µl	80	10/29/16	E 62.2	0
	20163070101	ERA 04281604: 80 µl & ERA 04281603: 80 µl	80	11/18/16	E 105	0
	20163070102	ERA 04281603: 80 µl & ERA 04281604: 80 µl	80	11/18/16	E 110	0
	20163150008	ERA 04281603: 80 µl & Crescent EN160610015: 80 µl	80	11/18/16	E 93.1	0
	20163150009	ERA 04281603: 80 µl & Crescent EN160610015: 80 µl	80	11/18/16	E 87.2	0
	20163630038	ERA 04281603: 100 µl & Abs 060916PHARM: 100 µl	80	01/19/17	E 151	0
	20170820004	ERA 04281603: 40 µl & Crescent EN160610015: 40 µl	80	04/07/17	E 69.7	0
	20171580165	ERA 04281604: 80 µl & ERA 04281603: 80 µl	80	06/17/17	E 121	0
	20171720142	Crescent EN160610015: 80 µl & ERA 04281603: 80 µl	80	07/14/17	E 158	0

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

THIABENDAZOLE

Method: 2440 Testid: 67455LCM56

Link to Individual Chart

False Positive & Negative Listing for THIABENDAZOLE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20160840084	ERA 0406-15-09: 20 µl & ERA 0406-15-07A: 20 µl	4.1	04/09/16	< 5.73	6.16
	20161260153	Abs 052215: 20 µl & ERA 0406-15-07A: 20 µl	4.1	05/11/16	< 4.1	6.02
	20161260154	Abs 052215: 20 µl & ERA 0406-15-07A: 20 µl	4.1	05/11/16	< 4.1	6.02

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

TIOTROPIUM

Method: 2440 Testid: 67508LCM56

Link to Individual Chart

False Positive & Negative Listing for TIOTROPIUM

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20161260153	Abs 052215: 20 µl & ERA 0406-15-07A: 20 µl	43.1	05/11/16	< 43.1	64.88
	20161260154	Abs 052215: 20 µl & ERA 0406-15-07A: 20 µl	43.1	05/11/16	< 43.1	64.88
	20172700086	ERA 06281702: 50 µl & ERA 06281703: 50 µl	200	10/21/17	< 200	1000
	20172980057	ERA 06281702: 20 µl & Abs 072517Pharm2: 20 µl	200	11/09/17	< 200	400
	20173060003	ERA 06281704: 50 µl & ERA 06281702: 50 µl	200	11/09/17	< 200	1000

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

TRAMADOL

Method: 2440 Testid: 67517LCM56

Link to Individual Chart

False Positive & Negative Listing for TRAMADOL

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20172070148	Abs 060916PHARM: 20 µl & Abs 071817Pharm: 20 µl	15	08/11/17	< 15	18.82

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

TRIAMTERENE

Method: 2440 Testid: 67475LCM56

Link to Individual Chart

False Positive & Negative Listing for TRIAMTERENE

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20160840084	ERA 0406-15-09: 20 µl & ERA 0406-15-07A: 20 µl	5.25	04/09/16	< 5.25	7.9
	20170110050	Abs 060916PHARM: 40 µl & ERA 04281604: 40 µl	5.2	02/07/17	< 7.31	13.28

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

TRIMETHOPRIM

Method: 2440 Testid: 67456LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

VALACYCLOVIR

Method: 2440 Testid: 67507LCM56

Link to Individual Chart

False Positive & Negative Listing for VALACYCLOVIR

Status	Lab ID	Spike Mix	Reporting Level	Analysis Date	Result Conc.	Expected Conc.
False Negative	20161260153	Abs 052215: 20 µl & ERA 0406-15-07A: 20 µl	163	05/11/16	< 163	244.3
	20161260154	Abs 052215: 20 µl & ERA 0406-15-07A: 20 µl	163	05/11/16	< 163	244.3

Updated 03/27/2018

Organic Blind Sample Program

False Positives & False Negatives

VENLAFAXINE

Method: 2440 Testid: 67534LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

VERAPAMIL

Method: 2440 Testid: 67472LCM56

Link to Individual Chart

Organic Blind Sample Program

False Positives & False Negatives

WARFARIN

Method: 2440 Testid: 67457LCM56

Link to Individual Chart